Archives
-
Cdk5, AMPK, and Neuronal Ferroptosis After Stroke
2026-09-30
The reference study identifies a mechanistic connection between Cdk5 activity, AMPK signaling, inflammatory microglial polarization, and hippocampal neuron ferroptosis after ischemic injury. Its combined mouse and cell-model design suggests that Cdk5 inhibition and AMPK activation can reduce neuroinflammation and iron-dependent neuronal damage, while also highlighting the need for direct iron measurements in follow-up studies.
-
DAPI Solution for IDD Cell-State Mapping
2026-09-30
DAPI and 4',6-Diamidino-2-Phenylindole provide a high-contrast nuclear readout for intervertebral disc degeneration research. This guide shows how to integrate DAPI with apoptosis, viability, microscopy, and flow cytometry assays without mistaking nuclear morphology for a stand-alone mechanistic endpoint.
-
Fluconazole Workflows for Fungal Resistance Research
2026-09-29
Build more interpretable antifungal assays with Fluconazole by controlling solvent, exposure, endpoint selection, and strain context. The workflow connects target-level inhibition with biofilm tolerance, Candida infection models, and resistance benchmarking against emerging antifungal strategies.
-
CCK Interneurons, BLA Inhibition, and Anxiety
2026-09-29
This study identifies basolateral amygdala cholecystokinin-expressing interneurons as a circuit element that can suppress local excitation and reduce stress-induced anxiety-like behavior in mice. By combining cell-type-specific chemogenetics, optogenetics, electrophysiology, and inhibitory-plasticity induction, the work links both acute transmission and longer-lasting plasticity to behavioral regulation.
-
DNMT3B, Nanaomycin A, and NEPC Translation
2026-09-28
DNMT3B is emerging as a mechanistic bridge between androgen-deprivation pressure, stemness, and neuroendocrine prostate cancer. This article translates the anchor study into a practical research strategy for evaluating (S,S)-Nanaomycin A as a DNMT3B-focused perturbation tool while keeping model selection, pharmacodynamic readouts, and translational limitations in view.
-
D-Mannitol for Osmotic Regulation Research
2026-09-28
D-Mannitol is a water-soluble reagent for controlled osmotic regulation research, renal function studies, and investigation of diuretic mechanisms. Use it in research workflows rather than as a substitute for a validated clinical formulation, and prepare solutions for near-term use because long-term solution storage is not recommended.
-
Two Signals, One mRNA: A Better Delivery Readout
2026-09-27
A translational framework for separating mRNA uptake from protein expression, using dual-reporter design, controlled validation, and the delivery lessons of spleen-selective LNP research.
-
Nadolol and Disease-State PK: A Better Study Design
2026-09-26
Nadolol (SQ-11725) is a useful probe for separating beta-adrenergic pharmacology from transporter-sensitive drug disposition. This article connects its cardiovascular research applications to disease-state pharmacokinetic findings while clearly distinguishing transferable study-design lessons from evidence that applies only to other compounds.
-
Storage Optimization for LNP Self-Replicating RNA Vaccines
2026-09-25
Kim and colleagues compared storage conditions for lipid nanoparticles carrying alphavirus-derived self-replicating RNA and found that RNase-free PBS with 10% sucrose at −20 °C preserved vaccine activity for 30 days at a level equivalent to freshly prepared material. The study also reports retained bioactivity after lyophilization, while underscoring that storage performance must be evaluated in the context of the complete LNP–RNA formulation.
-
Gestational PS-NPs and Adult Male Reproductive Injury
2026-09-25
A 2026 study combines testicular transcriptomics, serum metabolomics, and reproductive pathology to propose a partial adverse outcome pathway linking gestational polystyrene nano-plastics exposure with reproductive impairment in adult male offspring. Its integrated model identifies candidate molecular events for follow-up, while leaving key causal steps and exposure details for further investigation.
-
Cy5 amine (non-sulfonated): Labeling Workflow
2026-09-24
Cy5 amine is a primary-amine cyanine dye for coupling to compatible activated labeling partners when a bright, red-emitting fluorophore is needed. Because non-sulfonated Cy5 amine is insoluble in water, dissolve it in an organic solvent before controlled transfer into a compatible reaction; it is not a direct aqueous-labeling reagent or a diagnostic product.
-
Cy5-Labeled mRNA Delivery Assay Workflows
2026-09-24
Separate cellular uptake from successful translation with a dual-readout mRNA reporter: Cy5 tracks labeled RNA, while EGFP reports functional protein expression. This workflow shows how to use the reporter to compare delivery formulations, tune assay conditions, and troubleshoot mismatches between the two signals.
-
NAT1–ENO1–Lactate Signaling in Colorectal Cancer
2026-09-23
A 2026 MedComm study identifies NAT1 as a brake on ENO1-driven glycolysis and describes how lactate can activate TRAF6 to stabilize PD-L1 in colorectal cancer. The findings connect tumor metabolism with immune escape and provide a preclinical rationale for testing metabolic perturbations alongside checkpoint blockade, while leaving clinical benefit unestablished.
-
TaCRVP Hijacks Tomato Catalase to Suppress Defense
2026-09-23
The reference study identifies TaCRVP, a cysteine-rich effector in Tuta absoluta oral secretions, as a dual regulator of tomato SlCAT2. By enhancing catalase activity and protecting SlCAT2 from proteasomal turnover, TaCRVP suppresses hydrogen peroxide signaling, jasmonic acid-associated defenses, and plant resistance to feeding.
-
Clozapine N-oxide (CNO) for Chemogenetics
2026-09-22
Clozapine N-oxide (CNO) is a chemogenetic actuator used to engage engineered muscarinic DREADDs and study neuronal activity modulation. Its value is highest in controlled neuroscience research workflows that include receptor-negative controls, solvent controls, storage validation, and safeguards against clozapine-related off-target interpretation.